NRAS: position paper on biosimilar medicines

06

Maggio 2016

Particularly important from a patient perspective, is that it is vital that biosimilars are prescribed with care and thought and with proper consultation, care planning and shared decision making between the clinician and the patient

Documenti collegati:

NRAS_Biosimilars_Revised_Position_Paper_Final_2_March_2016.pdf

Sede legale: Via Molise, 16 – 73100 Lecce (LE)
Sede operativa : Via Miglietta, 5 c/o Asl Lecce (Ex Opis) – 73100 Lecce (LE)
Tel/Fax 0832 520165 - Email: info@apmarr.it - PEC: apmarr@legalmail.it
C.F.: 93059010756 - P.Iva: 04433470756 - Codice SDI: W7YVJK9
Privacy Policy